The total issue size of Atmastco IPO is up to ₹53.43 Cr whereas the issue size of the Zenith Drugs IPO is up to ₹33.94 Cr. The final issue price of Atmastco IPO is ₹77.00 per share and of Zenith Drugs IPO is ₹79.00 per share.
Atmastco IPO opens on Feb 15, 2024, while Zenith Drugs IPO opens on Feb 19, 2024. The closing date of Atmastco IPO and Zenith Drugs IPO is Feb 20, 2024, and Feb 22, 2024, respectively.
In the Atmastco IPO Retail Individual Investors (RII) are offered 34,69,600 shares while in Zenith Drugs IPO retail investors are offered 34,69,600 shares. Qualified Institutional Buyers (QIB) are offered in Atmastco IPO and 8,59,200 shares in Zenith Drugs IPO.